scholarly journals Clopidogrel variability: role of plasma protein binding alterations

2013 ◽  
Vol 75 (6) ◽  
pp. 1468-1477 ◽  
Author(s):  
Shobana Ganesan ◽  
Craig Williams ◽  
Cheryl L. Maslen ◽  
Ganesh Cherala
Author(s):  
Roger E. Fessey ◽  
Rupert P. Austin ◽  
Patrick Barton ◽  
Andrew M. Davis ◽  
Mark C. Wenlock

2001 ◽  
pp. 311-321 ◽  
Author(s):  
Quentin R. Smith ◽  
Carolyn Fisher ◽  
David D. Allen

1992 ◽  
Vol 76 (1) ◽  
pp. 65-70 ◽  
Author(s):  
Harry J. M. Lemmens ◽  
Anton G. L. Burm ◽  
James G. Bovill ◽  
Pim J. Hennis ◽  
Marina P. R. R. Gladines

2016 ◽  
Vol 105 (11) ◽  
pp. 3409-3414 ◽  
Author(s):  
Ravi Shankar Prasad Singh ◽  
Jatinder Kaur Mukker ◽  
Amelia N. Deitchman ◽  
Stephanie K. Drescher ◽  
Hartmut Derendorf

Bioanalysis ◽  
2021 ◽  
Author(s):  
Sheelan Ahmad ◽  
Daniel Baker ◽  
Darragh Murnane ◽  
Neil Spooner ◽  
Ute Gerhard

Aim: Determination of plasma protein binding ( PPB) is considered vital for better understanding of pharmacokinetic and pharmacodynamic activities of drugs due to the role of free concentration in pharmacological response. Methodology & results: Solid-phase microextraction (SPME) was investigated for measurement of PPB from biological matrices and compared with a gold standard approach (rapid equilibrium dialysis [RED]). Discussion & conclusion: SPME-derived values of PPB correlated well with literature values, and those determined by RED. Respectively, average protein binding across three concentrations by RED and SPME was 33.1 and 31.7% for metoprolol, 89.0 and 86.6% for propranolol and 99.2 and 99.0% for diclofenac. This study generates some evidence for SPME as an alternative platform for the determination of PPB.


Sign in / Sign up

Export Citation Format

Share Document